Seek prompt GP or prescriber advice if you experience: Severe or worsening pain at the injection site that persists beyond 24-48 hours or intensifies rather than improving Signs of infection including increasing redness spreading beyond the immediate injection site, warmth, swelling, pus or discharge, or fever Significant bruising that is extensive, painful, or accompanied by a hard lump under the skin Allergic reaction symptoms such as widespread rash, hives, facial swelling, difficulty breathing, or rapid heartbeatthese require immediate medical attention via 999 or A&E Persistent lumps or hard areas at injection sites that don't resolve within a few weeks, which may indicate lipohypertrophy Numbness, tingling, or shooting pain radiating from the injection site, suggesting possible nerve irritation Recurrent severe pain with every injection despite proper technique, which may indicate an underlying issue Injection site reactions can include mild, self-limiting symptoms such as redness, itching, or tenderness
Neill JC, Barnes S, Cook S, Grayson B, Idris N, et al
studies each performed propensity score matching on multiple factors, achieving baseline balance except for a residual higher BMI in the GLP-1 RA groups (tirzepatide, liraglutide, semaglutide)
Association of dietary patterns with risk of colorectal cancer subtypes classified by Fusobacterium nucleatum in tumor tissue
Epigallocatechin-3-Gallate attenuates microglial inflammation and neurotoxicity by suppressing the activation of canonical and noncanonical inflammasome via TLR4/NF-B pathway
If you see a drop of blood, use gentle pressure with a clean cotton pad or gauze
